ZBH Zimmer Biomet Holdings Inc

Price (delayed)

$119.79

Market cap

$25.03B

P/E Ratio

30.33

Dividend/share

$0.96

EPS

$3.95

Enterprise value

$31.61B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
The revenue has grown by 12% YoY
Zimmer Biomet Holdings's gross profit has increased by 11% YoY
ZBH's quick ratio is down by 23% YoY and by 6% QoQ
The net income has declined by 11% since the previous quarter

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
208.91M
Market cap
$25.03B
Enterprise value
$31.61B
Valuations
Price to earnings (P/E)
30.33
Price to book (P/B)
1.97
Price to sales (P/S)
3.17
EV/EBIT
32.76
EV/EBITDA
15.57
EV/Sales
4.01
Earnings
Revenue
$7.88B
EBIT
$964.9M
EBITDA
$2.03B
Free cash flow
$1.13B
Per share
EPS
$3.95
Free cash flow per share
$5.41
Book value per share
$60.85
Revenue per share
$37.76
TBVPS
$39.88
Balance sheet
Total assets
$24.01B
Total liabilities
$11.29B
Debt
$7.5B
Equity
$12.71B
Working capital
$2.37B
Liquidity
Debt to equity
0.59
Current ratio
1.81
Quick ratio
0.79
Net debt/EBITDA
3.24
Margins
EBITDA margin
25.8%
Gross margin
70.5%
Net margin
10.4%
Operating margin
11.9%
Efficiency
Return on assets
3.4%
Return on equity
6.6%
Return on invested capital
7.7%
Return on capital employed
4.6%
Return on sales
12.2%
Dividend
Dividend yield
0.8%
DPS
$0.96
Payout ratio
24.3%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
0.16%
1 week
-8.04%
1 month
-17.83%
1 year
-18.01%
YTD
-22.26%
QTD
-18.15%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.88B
Gross profit
$5.56B
Operating income
$941.7M
Net income
$819.3M
Gross margin
70.5%
Net margin
10.4%
The revenue has grown by 12% YoY
The net income has declined by 11% since the previous quarter
Zimmer Biomet Holdings's gross profit has increased by 11% YoY
The net margin has declined by 10% since the previous quarter

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
30.33
P/B
1.97
P/S
3.17
EV/EBIT
32.76
EV/EBITDA
15.57
EV/Sales
4.01
The EPS has contracted by 11% from the previous quarter
The stock's P/B is 24% below its last 4 quarters average of 2.6 and 14% below its 5-year quarterly average of 2.3
ZBH's equity is up by 7% year-on-year
ZBH's price to sales (P/S) is 26% lower than its last 4 quarters average of 4.3 and 7% lower than its 5-year quarterly average of 3.4
The revenue has grown by 12% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
Zimmer Biomet Holdings's return on equity has decreased by 12% QoQ
The ROA has contracted by 11% from the previous quarter
The ROS has contracted by 9% from the previous quarter
The ROIC has decreased by 6% QoQ

Dividends

What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.8%
Payout ratio
24.3%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 113% higher than the total liabilities
ZBH's quick ratio is down by 23% YoY and by 6% QoQ
The current ratio has contracted by 20% YoY
The debt is 41% smaller than the equity
The debt to equity has declined by 16% year-on-year and by 4.8% since the previous quarter
The debt has declined by 9% year-on-year and by 4.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.